Pharmacoepidemiological Approaches for Population-Based Hypothesis Testing
Publisher
Springer New York
Reference39 articles.
1. Strom BL (1987) The promise of pharmacoepidemiology. Annu Rev Pharmacol Toxicol 27:71–86
2. Meyboom RHB, Egberts ACG, Hekster YA et al (1997) Principles of signal detection in pharmaovigilance. Drug Saf 16:355–365
3. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW et al (1995) The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 274:620–625
4. Kleinbloesem CH, van Brummelen P, Danhof M, Faber H, Urquhart J, Breimer DD (1987) Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin Pharmacol Ther 41:26–30
5. Leufkens HGM, Urquhart J (1994) Variability in patterns of drug usage. J Pharm Pharmacol 46(Suppl I):433–437